224 related articles for article (PubMed ID: 26244648)
21. Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.
Alatri A; Schoepfer A; Fournier N; Engelberger RP; Safroneeva E; Vavricka S; Biedermann L; Calanca L; Mazzolai L;
Scand J Gastroenterol; 2016 Oct; 51(10):1200-5. PubMed ID: 27211077
[TBL] [Abstract][Full Text] [Related]
22. Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.
Godat S; Fournier N; Safroneeva E; Juillerat P; Nydegger A; Straumann A; Vavricka S; Biedermann L; Greuter T; Fraga M; Abdelrahman K; Hahnloser D; Sauter B; Rogler G; Michetti P; Schoepfer AM;
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):612-620. PubMed ID: 29384798
[TBL] [Abstract][Full Text] [Related]
23. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000.
Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N
Digestion; 2023; 104(4):328-334. PubMed ID: 36893744
[TBL] [Abstract][Full Text] [Related]
24. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
[TBL] [Abstract][Full Text] [Related]
26. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
27. Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort.
Koutroubakis IE; Ramos-Rivers C; Regueiro M; Koutroumpakis E; Click B; Schwartz M; Swoger J; Baidoo L; Hashash JG; Barrie A; Dunn MA; Binion DG
J Clin Gastroenterol; 2016 Sep; 50(8):638-43. PubMed ID: 26485103
[TBL] [Abstract][Full Text] [Related]
28. Rheumatic manifestations of inflammatory bowel diseases: A study from the Middle East.
Hammoudeh M; Elsayed E; Al-Kaabi S; Sharma M; Elbadri M; Chandra P; Abu Nahia N; Hammoudeh S
J Int Med Res; 2018 Sep; 46(9):3837-3847. PubMed ID: 29961404
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.
Voegtlin M; Vavricka SR; Schoepfer AM; Straumann A; Voegtlin J; Rogler G; Ballabeni P; Pittet V; Buser A; Fried M; Beglinger C;
J Crohns Colitis; 2010 Dec; 4(6):642-8. PubMed ID: 21122574
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of inflammatory bowel disease in Japanese psoriatic patients.
Masaki S; Bayaraa B; Imafuku S
J Dermatol; 2019 Jul; 46(7):590-594. PubMed ID: 31087586
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey.
Tozun N; Atug O; Imeryuz N; Hamzaoglu HO; Tiftikci A; Parlak E; Dagli U; Ulker A; Hulagu S; Akpinar H; Tuncer C; Suleymanlar I; Ovunc O; Hilmioglu F; Aslan S; Turkdogan K; Bahcecioglu HI; Yurdaydin C;
J Clin Gastroenterol; 2009 Jan; 43(1):51-7. PubMed ID: 18724251
[TBL] [Abstract][Full Text] [Related]
33. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
[TBL] [Abstract][Full Text] [Related]
34. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
[TBL] [Abstract][Full Text] [Related]
35. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life.
Palm Ø; Bernklev T; Moum B; Gran JT
J Rheumatol; 2005 Sep; 32(9):1755-9. PubMed ID: 16142874
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
37. [Patients with inflammatory bowel disease in specialist gastroenterology practice: a prospective survey].
Beltinger J; Froehlich F;
Praxis (Bern 1994); 2005 Mar; 94(12):459-65. PubMed ID: 15846950
[TBL] [Abstract][Full Text] [Related]
38. Risk factors of work disability in patients with inflammatory bowel disease--a Dutch nationwide web-based survey: work disability in inflammatory bowel disease.
van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B; ;
J Crohns Colitis; 2014 Jul; 8(7):590-7. PubMed ID: 24351733
[TBL] [Abstract][Full Text] [Related]
39. Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab.
Thiebault H; Boyard-Lasselin P; Guignant C; Guillaume N; Wacrenier A; Sabbagh C; Rebibo L; Brazier F; Meynier J; Nguyen-Khac E; Dupas JL; Goëb V; Fumery M
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):876-81. PubMed ID: 27101404
[TBL] [Abstract][Full Text] [Related]
40. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
